Dr. Dimitri Carlos Cassimatis, MD

Dr. Cassimatis practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Cassimatis' NPI, 1598737421, was assigned on February 4, 2006. Dr. Cassimatis graduated from Harvard Medical School in 1999. Dr. Cassimatis holds Georgia license 063839.

Dr. Cassimatis' primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Cassimatis' primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Cassimatis is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Cassimatis to 1 more hospital, 1 clinical lab and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cassimatis practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Cassimatis' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Cassimatis' licenses on file in 2 states: Georgia and Florida.

CMS data shows 720 Medicare services from Dr. Cassimatis across 7 procedure codes in 2024, for 480 Medicare patients. Medicare paid $19,113 for them.

CMS counts 480 Medicare patients who saw Dr. Cassimatis in 2024. The largest group is 75 to 84, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cassimatis' median patient age at 71, with 55% women.

In 2024, Dr. Cassimatis wrote 1,311 Medicare Part D claims for 142 patients. 83% of them were for generic drugs. CMS names the drug for 1,111 of them, across 26 drugs with 11 or more claims each, at $191,699 in total drug cost. In 2023, CMS named 934 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Cassimatis for performance year 2024, reported through an alternative payment model (APM). Dr. Cassimatis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cassimatis as offering telehealth.

Dmand AI links 3 papers to Dr. Cassimatis, published from 2015 to 2022. Dr. Cassimatis' most frequent co-authors are Anurag Mehta, MD and Laurence S. Sperling, MD.

CMS Open Payments shows 1 general payment to Dr. Cassimatis from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $93.

Dr. Cassimatis graduated from Harvard Medical School in 1999.